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Calibration Experiments Conducted for 
Noninvasive Blood Glucose Sensing 
Through the Eye 
There are more than 16 million diabetics in the United States and more than 100 million 
worldwide. Diabetes can lead to severe complications over time such as blindness, renal 
and cardiovascular diseases, and peripheral neuropathy in the limbs. Poor blood 
circulation in diabetics can lead to gangrene and the subsequent amputation of 
extremities. In addition, this pathology is the fourth leading cause of death in the United 
States. The most effective way to manage diabetes is frequent blood glucose monitoring 
performed by the patients themselves. However, because of pain, inconvenience, and the 
fear of developing infections from finger-prick blood tests or implants, many patients 
monitor their blood glucose levels less frequently than is recommended by their 
physicians. Therefore, a noninvasive, painless, and convenient method to monitor blood 
glucose would greatly benefit diabetics.  
Likewise, detecting, preventing, and treating the untoward effects of prolonged space 
travel (e.g., a human mission to Mars) in real-time requires the development of 
noninvasive diagnostic technologies that are compact and powerful. As a "window to the 
body," the eye offers the opportunity to use light in various forms to detect ocular and 
systemic abnormalities long before clinical symptoms appear and to help develop 
preventative and therapeutic countermeasures early. The noninvasive feature of these 
technologies permits frequent repetition of tests, enabling an evaluation of the response to 
therapy.  
Certain molecules (e.g., glucose) possess chiral properties: they will rotate a plane of 
polarized light to the right (clockwise). The rate of rotation is directly proportional to the 
amount of glucose present in a solution. The aqueous humor of the eye exhibits low 
scattering properties, and its glucose concentration closely matches blood glucose levels. 
A glucose molecule rotates the plane of polarization of incident polarized light by an 
angle θα that is proportional to the path length l and the concentration c in the sample. 
The substance-specific proportionality factor [α]λ denotes the optical rotatory power, 
which is a function of the wavelength λ. By knowing this quantity at the wavelength and 
optical path length l used and by observing the polarization rotation θα, one can calculate 
the glucose concentration c.  
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Principle of operation. Biot's law: θα = [α]λ/c.  
The preferred test site for the polarimetric measurement of glucose concentration in the 
human body is the aqueous humor of the eye: the clear fluid between the cornea and 
crystalline lens in the eye's anterior chamber. This fluid is an ultra-filtrate of blood 
containing most of the molecules found in serum, including glucose, at concentrations 
that are reflective of serum levels in the human body. Therefore, the aqueous humor can 
act as an exceptional optical window to measure the glucose levels of diabetics without 
contact.  
In our experimental setup, the aqueous humor is optically accessed with a circularly 
polarized light beam reflected at the Brewster's angle φB off the eye lens. On its way out 
of the eye, the resulting reflected linearly polarized light constitutes the measured 
quantity for the sensor. The application of a multiwavelength light source permits 
spectrally resolved signal detection by the angle-detection unit so that the device can 
benefit from the specific wavelength dependence of the optical rotatory power of glucose. 
Therefore, the influence of optically active confounders1 and of changes in the 
polarization state induced by the geometry of the setup are mostly eliminated. For 
simultaneous measurement of the optical path length inside the aqueous humor, a path-
length detection unit was built on the basis of low-coherence interferometry.  
 
Schematic diagram of the apparatus Iah, reflected optical path length. 
Long description. This diagram shows light from a multiwavelength light source passing through a linear 
polarizer and a one-fourth wavelength retarder through the aqueous humor to the lens of the eye. It returns 
to the control unit for data analysis (glucose concentration) via a beam splitter and an angle-detection unit 
and via mirrors and a path-length detection unit. 
Preliminary proof-of-concept calibration experiments using aqueous glucose samples 
were conducted at the NASA Glenn Research Center. The results showed good linearity 
(correlation coefficient, r = 0.986) and high sensitivity (angle of rotation, σ = 1.38 
millidegrees corresponding to a glucose concentration, c, of 77 mg/dl). Efforts are 
underway to further improve the sensitivity and repeatability and to reduce the size and 
cost of the sensor. The ultimate goal is a portable, easy-to-use, reliable measurement 
device for daily patient medical care and better diabetes management.  
 
Instrument calibration.  
 
1Molecules other than glucose (e.g., albumins).  
 
Reference  
1. Ansari, Rafat R.; Böckle, Stefan; and Rovati, Luigi: New Optical Scheme for a 
Polarimetric-Based Glucose Sensor. J. Biomed. Opt., vol. 9, no. 1, 2004, pp. 103-
115.  
Glenn contact: Dr. Rafat R. Ansari, 216-433-5008, Rafat.R.Ansari@nasa.gov  
Authors: Dr. Rafat R. Ansari, Dr. Stefan Bockle, Dr. Kwang I. Suh, and Dr. Luigi L. 
Rovati  
Headquarters program office: OBPR  
Programs/Projects: Microgravity Science  
Special recognition: U.S. Patent 6,704,588 awarded March 9, 2004.  
 
